DC Field | Value | Language |
---|---|---|
dc.contributor.author | Gilhye Lee | - |
dc.contributor.author | Jung Hee Kim | - |
dc.contributor.author | Hyun-Jae Jang | - |
dc.contributor.author | Ji Won Park | - |
dc.contributor.author | Jae-Won Lee | - |
dc.contributor.author | Ok-Kyoung Kwon | - |
dc.contributor.author | J H Kim | - |
dc.contributor.author | Kyung Seop Ahn | - |
dc.date.accessioned | 2021-09-07T15:30:26Z | - |
dc.date.available | 2021-09-07T15:30:26Z | - |
dc.date.issued | 2021 | - |
dc.identifier.issn | 1741-427X | - |
dc.identifier.uri | https://oak.kribb.re.kr/handle/201005/24702 | - |
dc.description.abstract | Pyrus pyrifolia Nakai (P. pyrifolia) has been traditionally used in East Asia to treat diseases such as phlegm, cough, hangover, and fever. However, there is no investigation that evaluates the biological activities of the leaves of P. pyrifolia. This study aims at describing the anti-inflammatory effects of PP, a bioactive fraction from the leaves of P. pyrifolia, in lipopolysaccharide (LPS)-stimulated THP-1 cells. Initially, PP decreased the protein and RNA expression of TNF-α, MCP-1, IL-8, and IL-6 induced by LPS. Moreover, PP attenuated the phosphorylation of p38, JNK, and ERK. In addition, after stimulation with LPS, the degradation of IκB-α was suppressed by PP, and the phosphorylation of IκB-α and p65 was suppressed by PP. Additionally, PP increased HO-1, which controls the production of inflammatory molecules, by activating Nrf2. These results indicated that PP could be used as an anti-inflammatory drug to promote wellness. | - |
dc.publisher | Hindawi Ltd | - |
dc.title | Anti-inflammatory effects of the fraction from the leaves of Pyrus pyrifolia on LPS-stimulated THP-1 cells | - |
dc.title.alternative | Anti-inflammatory effects of the fraction from the leaves of Pyrus pyrifolia on LPS-stimulated THP-1 cells | - |
dc.type | Article | - |
dc.citation.title | Evidence-Based Complementary and Alternative Medicine | - |
dc.citation.number | 0 | - |
dc.citation.endPage | 4946241 | - |
dc.citation.startPage | 4946241 | - |
dc.citation.volume | 2021 | - |
dc.contributor.affiliatedAuthor | Gilhye Lee | - |
dc.contributor.affiliatedAuthor | Jung Hee Kim | - |
dc.contributor.affiliatedAuthor | Hyun-Jae Jang | - |
dc.contributor.affiliatedAuthor | Ji Won Park | - |
dc.contributor.affiliatedAuthor | Jae-Won Lee | - |
dc.contributor.affiliatedAuthor | Ok-Kyoung Kwon | - |
dc.contributor.affiliatedAuthor | Kyung Seop Ahn | - |
dc.contributor.alternativeName | 이길혜 | - |
dc.contributor.alternativeName | 김정희 | - |
dc.contributor.alternativeName | 장현재 | - |
dc.contributor.alternativeName | 박지원 | - |
dc.contributor.alternativeName | 이재원 | - |
dc.contributor.alternativeName | 권옥경 | - |
dc.contributor.alternativeName | 김재홍 | - |
dc.contributor.alternativeName | 안경섭 | - |
dc.identifier.bibliographicCitation | Evidence-Based Complementary and Alternative Medicine, vol. 2021, pp. 4946241-4946241 | - |
dc.identifier.doi | 10.1155/2021/4946241 | - |
dc.description.journalClass | Y | - |
There are no files associated with this item.
Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.